MMP-2 contributes to cancer-nerve crosstalk in breast, prostate, and pancreatic cancers, whereas neural cell secretion of CCL2 is a contributor to cervical, prostate, and pancreatic cancer PNI [26–28, 61–63]. This evidence concerns the gene CCL2 and pancreatic neoplasm.